Cargando…

Patient and health facility attributes associated with retention and virologic suppression in private for-profit health facilities in Nigeria

BACKGROUND: In Nigeria, private for-profit health facilities present an opportunity to achieve the UNAIDS 95-95-95 HIV targets because of their reach and patronage. However, little is known about determinants of outcomes in these facilities. This study describes patient outcomes and the patient and...

Descripción completa

Detalles Bibliográficos
Autores principales: Aina, Muyi, Yesufu, Zeena, Salisu, Abdulateef, Ezeanolue, Echezona, Mensah, Charles, Dakum, Patrick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8864871/
https://www.ncbi.nlm.nih.gov/pubmed/35193597
http://dx.doi.org/10.1186/s12981-022-00438-3
_version_ 1784655540254670848
author Aina, Muyi
Yesufu, Zeena
Salisu, Abdulateef
Ezeanolue, Echezona
Mensah, Charles
Dakum, Patrick
author_facet Aina, Muyi
Yesufu, Zeena
Salisu, Abdulateef
Ezeanolue, Echezona
Mensah, Charles
Dakum, Patrick
author_sort Aina, Muyi
collection PubMed
description BACKGROUND: In Nigeria, private for-profit health facilities present an opportunity to achieve the UNAIDS 95-95-95 HIV targets because of their reach and patronage. However, little is known about determinants of outcomes in these facilities. This study describes patient outcomes and the patient and health facility characteristics associated with these outcomes in adults receiving HIV treatment in private facilities in the Federal Capital Territory (FCT), Benue and Nasarawa states in north-central Nigeria. METHODS: A retrospective longitudinal analysis of program data collected between 2013 and 2019 was done. Patient attributes and outcomes were compared across the two states and FCT. Incidence rates were determined for all cause exit, mortality and loss to follow up (LTFU). Cox proportional hazard models were used to identify associations between patient and facility attributes and these outcomes. Bivariate and multivariate logistic regression models were used to determine the factors associated with viral suppression among the study participants. RESULTS: Of the 22,010 study subjects, 42.7%, 22.2% and 35.1%, respectively, were in Benue, FCT and Nasarawa. Almost a third (31.8%) had received antiretroviral treatment (ART) for less than a year at censoring. Incidence rates for all-cause exit, mortality and loss to follow up (LTFU) were 17.2 (95% CI 16.8, 17.5), 2.1 (95% CI 2.0, 2.2), and 11.2 (95% CI 10.8, 11.8) per 100 person years respectively. Males had higher risks of death (HR = 1.47, 95% CI 1.25–1.73), and LTFU (HR = 1.08, 95% CI 1.00–1.16). Age at ART start showed a dose–response association with both mortality and LTFU. Care at model facilities (OR = 2.16, p < 0.001), Zidovudine (AZT)-based regimens (OR = 2.00, p < 0.001), and lowest quartile baseline CD4 + count (OR = 2.40, p < 0.001) were associated with regimen switch. 75.6% of subjects were viral suppressed. Male gender (OR = 0.84, p = 0.025); AZT-based regimen (OR = 0.72, p < 0.001), age in the bottom quartile (OR = 0.71, p = 0.002) were associated with virally suppression. CONCLUSION: Private for-profit facilities are a major provider of HIV and other health services in Nigeria. With appropriate technical support and engagement, they can help accelerate efforts to achieve epidemic control of HIV in Nigeria, and contribute to achievement of UNAIDS 95-95-95 target by 2030.
format Online
Article
Text
id pubmed-8864871
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-88648712022-02-28 Patient and health facility attributes associated with retention and virologic suppression in private for-profit health facilities in Nigeria Aina, Muyi Yesufu, Zeena Salisu, Abdulateef Ezeanolue, Echezona Mensah, Charles Dakum, Patrick AIDS Res Ther Research BACKGROUND: In Nigeria, private for-profit health facilities present an opportunity to achieve the UNAIDS 95-95-95 HIV targets because of their reach and patronage. However, little is known about determinants of outcomes in these facilities. This study describes patient outcomes and the patient and health facility characteristics associated with these outcomes in adults receiving HIV treatment in private facilities in the Federal Capital Territory (FCT), Benue and Nasarawa states in north-central Nigeria. METHODS: A retrospective longitudinal analysis of program data collected between 2013 and 2019 was done. Patient attributes and outcomes were compared across the two states and FCT. Incidence rates were determined for all cause exit, mortality and loss to follow up (LTFU). Cox proportional hazard models were used to identify associations between patient and facility attributes and these outcomes. Bivariate and multivariate logistic regression models were used to determine the factors associated with viral suppression among the study participants. RESULTS: Of the 22,010 study subjects, 42.7%, 22.2% and 35.1%, respectively, were in Benue, FCT and Nasarawa. Almost a third (31.8%) had received antiretroviral treatment (ART) for less than a year at censoring. Incidence rates for all-cause exit, mortality and loss to follow up (LTFU) were 17.2 (95% CI 16.8, 17.5), 2.1 (95% CI 2.0, 2.2), and 11.2 (95% CI 10.8, 11.8) per 100 person years respectively. Males had higher risks of death (HR = 1.47, 95% CI 1.25–1.73), and LTFU (HR = 1.08, 95% CI 1.00–1.16). Age at ART start showed a dose–response association with both mortality and LTFU. Care at model facilities (OR = 2.16, p < 0.001), Zidovudine (AZT)-based regimens (OR = 2.00, p < 0.001), and lowest quartile baseline CD4 + count (OR = 2.40, p < 0.001) were associated with regimen switch. 75.6% of subjects were viral suppressed. Male gender (OR = 0.84, p = 0.025); AZT-based regimen (OR = 0.72, p < 0.001), age in the bottom quartile (OR = 0.71, p = 0.002) were associated with virally suppression. CONCLUSION: Private for-profit facilities are a major provider of HIV and other health services in Nigeria. With appropriate technical support and engagement, they can help accelerate efforts to achieve epidemic control of HIV in Nigeria, and contribute to achievement of UNAIDS 95-95-95 target by 2030. BioMed Central 2022-02-22 /pmc/articles/PMC8864871/ /pubmed/35193597 http://dx.doi.org/10.1186/s12981-022-00438-3 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Aina, Muyi
Yesufu, Zeena
Salisu, Abdulateef
Ezeanolue, Echezona
Mensah, Charles
Dakum, Patrick
Patient and health facility attributes associated with retention and virologic suppression in private for-profit health facilities in Nigeria
title Patient and health facility attributes associated with retention and virologic suppression in private for-profit health facilities in Nigeria
title_full Patient and health facility attributes associated with retention and virologic suppression in private for-profit health facilities in Nigeria
title_fullStr Patient and health facility attributes associated with retention and virologic suppression in private for-profit health facilities in Nigeria
title_full_unstemmed Patient and health facility attributes associated with retention and virologic suppression in private for-profit health facilities in Nigeria
title_short Patient and health facility attributes associated with retention and virologic suppression in private for-profit health facilities in Nigeria
title_sort patient and health facility attributes associated with retention and virologic suppression in private for-profit health facilities in nigeria
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8864871/
https://www.ncbi.nlm.nih.gov/pubmed/35193597
http://dx.doi.org/10.1186/s12981-022-00438-3
work_keys_str_mv AT ainamuyi patientandhealthfacilityattributesassociatedwithretentionandvirologicsuppressioninprivateforprofithealthfacilitiesinnigeria
AT yesufuzeena patientandhealthfacilityattributesassociatedwithretentionandvirologicsuppressioninprivateforprofithealthfacilitiesinnigeria
AT salisuabdulateef patientandhealthfacilityattributesassociatedwithretentionandvirologicsuppressioninprivateforprofithealthfacilitiesinnigeria
AT ezeanolueechezona patientandhealthfacilityattributesassociatedwithretentionandvirologicsuppressioninprivateforprofithealthfacilitiesinnigeria
AT mensahcharles patientandhealthfacilityattributesassociatedwithretentionandvirologicsuppressioninprivateforprofithealthfacilitiesinnigeria
AT dakumpatrick patientandhealthfacilityattributesassociatedwithretentionandvirologicsuppressioninprivateforprofithealthfacilitiesinnigeria